Skip to Content

NVR BCR (Tasigna 150 mg)

Generic Name: nilotinib

Pill with imprint NVR BCR is Red, Capsule-shape and has been identified as Tasigna 150 mg. It is supplied by Novartis Pharmaceuticals.

Tasigna is used in the treatment of chronic myelogenous leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Tasigna 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for NVR BCR

Tasigna

Generic Name:
nilotinib
Imprint:
NVR BCR
Strength:
150 mg
Color:
Red
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
BCR-ABL tyrosine kinase inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Novartis Pharmaceuticals
Inactive Ingredients:
silicon dioxide
crospovidone
gelatin
lactose monohydrate
magnesium stearate
ferric oxide red
titanium dioxide
ferric oxide yellow
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide